NIH program to accelerate therapies for arthritis, lupus releases first datasets

(NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases) Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the Accelerating Medicines Partnership for Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Phase I study are now available to the research community. Scientists from across the biomedical research community can access the AMP RA/SLE datasets to explore important research questions about these autoimmune conditions.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news